论文部分内容阅读
本文主要论述的是在临床实践中观察通心络胶囊对高血压伴糖尿病等症状的治疗效果及其安全性能。主要方法如下:将医院内高血压伴糖尿病的确诊患者100名,采取随即数字表的方法分为两组,即为治疗组和对照组。治疗组:要求患者每天晨起后口服一粒5mg的非洛地平缓释片,每日一次;一粒30mg的格列齐特缓释片,每日一次;外加通心络胶囊,每次3粒,每日3次。对照组:患者每天晨起后口服一粒5mg的非洛地平缓释片,每日一次;一粒30mg的格列齐特缓释片,每日一次,不服用通心络胶囊。接下来对比观察两组患者的血糖、血压和血脂在治疗前后的变化情况。通过观察得出结论 :通心络胶囊对高血压伴糖尿病患者的治疗效果十分显著。
This article mainly discusses the clinical effect of Tongxinluo capsule on hypertension and other symptoms of diabetes and its safety performance. The main methods are as follows: 100 patients diagnosed with hypertension in hospital were divided into two groups according to the method of digital table, namely the treatment group and the control group. Treatment group: Patients are required to take a 5mg felodipine sustained-release tablets orally every morning after a day; one 30mg gliclazide sustained-release tablets once daily; and Tongxinluo capsules 3 Granules, 3 times a day. Control group: Patients taking a 5mg felodipine sustained-release tablets orally every morning after a day, once daily; a 30mg gliclazide sustained-release tablets, once daily, do not take Tongxinluo capsules. Then compare the two groups were observed in patients with blood glucose, blood pressure and blood lipid changes before and after treatment. Through the observation that the conclusion: Tongxinluo capsule on hypertension patients with diabetes treatment effect is very significant.